Citations

Clear

2429 citation(s) found for "Shah, SS".

Interns' Success With Clinical Procedures in Infants After Simulation Training
Kessler, David , Arteaga, Grace M. , Ching, Kevin , Haubner, Laura, Kamdar, Gunjan, Krantz, Amanda, Lindower, Julie B. , Petrescu, Matei, Pusic, Martin , Rocker, Joshua, Shah, Nikhil , Strother, Christopher , Tilt, Lindsey, Weinberg, Eric, Chang, Todd P. , Fein, Daniel M., Auerbach, Marc , Miller, Michael J. , Pusic, Martin V

Mayo Clinic

Pediatrics | February 26, 2013 | Volume: 131 | Issue: 3 | Pages: e811-e811

10.1542/peds.2012-0607 | PMID 23439901 Get It

BACKGROUND AND OBJECTIVE: Simulation-based medical education (SBME) is used to teach residents. However, few studies have evaluated its clinical impact. The goal of this study was to evaluate the impact of an SBME session on pediatric interns’ clinical procedural success. METHODS: This randomized trial was conducted at 10 academic medical centers. Interns were surveyed on infant lumbar puncture (ILP) and child intravenous line placement (CIV) knowledge and watched audiovisual expert modeling of both procedures. Participants were randomized to SBME mastery learning for ILP or CIV and for 6 succeeding months reported clinical performance for both procedures. ILP success was defined as obtaining a sample on the first attempt with <1000 red blood cells per high-power field or fluid described as clear. CIV success was defined as placement of a functioning catheter on the first try. Each group served as the control group for the procedure for which they did not receive the intervention. RESULTS: Two-hundred interns participated (104 in the ILP group and 96 in the CIV group). Together, they reported 409 procedures. ILP success rates were 34% (31 of 91) for interns who received ILP mastery learning and 34% (25 of 73) for controls (difference: 0.2% [95% confidence interval: –0.1 to 0.1]). The CIV success rate was 54% (62 of 115) for interns who received CIV mastery learning compared with 50% (58 of 115) for controls (difference: 3% [95% confidence interval: –10 to 17]). CONCLUSIONS: Participation in a single SBME mastery learning session was insufficient to affect pediatric interns’ subsequent procedural success.
Intravascular Catheter-Related Bloodstream Infection
Shah, Harshal , Bosch, Wendelyn , Thompson, Kristine M., Hellinger, Walter C.

Mayo Clinic

The Neurohospitalist | February 16, 2013 | Volume: 3 | Issue: 3 | Pages: 144-151

10.1177/1941874413476043 | PMID 24167648 Get It

Intravascular catheters required for the care of many hospitalized patients can give rise to bloodstream infection, a complication of care that has occurred most frequently in intensive care unit (ICU) settings. Elucidation of the pathogenesis of catheter-related bloodstream infections (CRBSIs) has guided development of effective diagnostic, management, and prevention strategies. When CRBSIs occur in the ICU, physicians must be prepared to recognize and treat them. Prevention of these infections requires careful attention to optimal catheter selection, insertion and maintenance, and to removal of catheters when they are no longer needed. This review provides a succinct summary of the epidemiology, pathogenesis, and microbiology of CRBSIs and a review of current guidance for the diagnosis, management, and prevention of these infections.
The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension
Seo, Yeon Seok , Shah, Vijay H.

Mayo Clinic

Clinical and Molecular Hepatology | January 4, 2013 | Volume: 18 | Issue: 4 | Pages: 337

10.3350/cmh.2012.18.4.337 | PMID 23323248 Get It

Faculty Opinions recommendation of Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice.
Shah, Vijay H.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | December 19, 2012 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717967686.793467352 Get It

Tumor-Induced Osteomalacia Caused by Primary Fibroblast Growth Factor 23 Secreting Neoplasm in Axial Skeleton: A Case Report
Gandhi, Gunjan Y. , Shah, Aashish A., Wu, Kevin J. , Shoraka, Ali Reza, Gupta, Vivek

Mayo Clinic

Case Reports in Endocrinology | December 17, 2012 | Volume: 2012 | Issue: No issue available | Pages: 1-5

10.1155/2012/185454 | PMID 23346426 Get It

We report the case of a 66-year-old woman with tumor-induced osteomalacia (TIO) caused by fibroblast growth factor 23 (FGF-23) secreting mesenchymal tumor localized in a lumbar vertebra and review other cases localized to the axial skeleton. She presented with nontraumatic low back pain and spontaneous bilateral femur fractures. Laboratory testing was remarkable for low serum phosphorus, phosphaturia, and significantly elevated serum FGF-23 level. Magnetic resonance imaging (MRI) of the lumbar spine showed a focal lesion in the L-4 vertebra which was hypermetabolic on positron emission tomography (PET) scan. A computed tomography (CT) guided needle biopsy showed a low grade spindle cell neoplasm with positive FGF-23 mRNA expression by reverse transcriptase polymerase chain reaction (RT-PCR), confirming the diagnosis of a phosphaturic mesenchymal tumor mixed connective tissue variant (PMTMCT). The patient elected to have surgery involving anterior resection of L-4 vertebra with subsequent normalization of serum phosphorus. Including the present case, we identified 12 cases of neoplasms localized to spine causing TIO. To our knowledge, this paper represents the first documented case of lumbar vertebra PMT causing TIO. TIO is a rare metabolic bone disorder that carries a favorable prognosis. When a lesion is identifiable, surgical intervention is typically curative.
Disparities in Access to Hospitals with Robotic Surgery for Patients with Prostate Cancer Undergoing Radical Prostatectomy
Kim, Simon P. , Boorjian, Stephen A. , Shah, Nilay D., Weight, Christopher , Tilburt, Jon C. , Han, Leona C., Thompson, R. Houston, Sun, Maxine , Moriarty, James P. , Karnes, R. Jeffrey , Trinh, Quoc‐Dien

Mayo Clinic

Journal of Urology | December 17, 2012 | Volume: 189 | Issue: 2 | Pages: 514-520

10.1016/j.juro.2012.09.033 | PMID 23253307 Get It

American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
Smallridge, Robert C., Sylvia, L. , Bible, Keith C. , Brierley, James D. , Burman, Kenneth D. , Kebebew, Electron , Lee, Nancy Y. , Rosenthal, M. Sara, Shah, Manisha H. , Shaha, Ashok R. , Ass, R. Michael Tuttle for the American Thyroid, Ain, Kenneth B. , Nikiforov, Yuri E.

Mayo Clinic

Thyroid | November 6, 2012 | Volume: 22 | Issue: 11 | Pages: 1104-1139

10.1089/thy.2012.0302 | PMID 23130564 Get It

Rare variants in XRCC2 as breast cancer susceptibility alleles: Table 1
Hilbers, Florentine , Hoogerbrugge, Nicoline, Oosterwijk, Jan C., Collée, Margriet J., Peterlongo, Paolo , Radice, Paolo , Manoukian, Siranoush , Feroce, Irène , Capra, F, Guidugli, Lucia, Offit, Kenneth, Shah, Sohela, Campbell, Ian , Thompson, Ella R. , James, Paul A. , Trainer, Alison H., Gracia, Javier, Devilee, Peter , Hoogerbrugge, Nicoline , Wijnen, Juul , Hoogerbrugge, Nicoline, Collée, Margriet , Couch, Fergus J. , Wang, Xianshu , Benı́tez, Javier , Asperen, Christi J. van , James, Paul , Peterlongo, Paolo , Radice, Paolo , Campbell, Ian G , Devilee, Peter , Manoukian, Siranoush

Mayo Clinic

Journal of Medical Genetics | October 10, 2012 | Volume: 49 | Issue: 10 | Pages: 618-620

10.1136/jmedgenet-2012-101191 | PMID 23054243 Get It

Background Recently, rare germline variants in XRCC2 were detected in non-BRCA1/2 familial breast cancer cases, and a significant association with breast cancer was reported. However, the breast cancer risk associated with these variants needs further evaluation. Methods The coding regions and exon–intron boundaries of XRCC2 were scanned for mutations in an international cohort of 3548 non-BRCA1/2 familial breast cancer cases and 1435 healthy controls using various mutation scanning methods. Predictions on functional relevance of detected missense variants were obtained from three different prediction algorithms. Results The only protein-truncating variant detected was found in a control. Rare non-protein-truncating variants were detected in 20 familial cases (0.6%) and nine healthy controls (0.6%). Although the number of variants predicted to be damaging or neutral differed between prediction algorithms, in all instances these categories were evenly represented among cases and controls. Conclusions Our data do not confirm an association between XRCC2 variants and breast cancer risk, although a relative risk smaller than two could not be excluded. Variants in XRCC2 are unlikely to explain a substantial proportion of familial breast cancer.
Predictive Value of Current Imaging Modalities for the Detection of Urolithiasis During Pregnancy: a Multicenter, Longitudinal Study
White, Wesley M. , Johnson, Elizabeth B., Zite, Nikki B., Beddies, John, Krambeck, Amy E. , Hyams, Elias S. , Marien, Tracy , Shah, Ojas , Matlaga, Brian R., Pais, Vernon M.

Mayo Clinic

Journal of Urology | September 24, 2012 | Volume: 189 | Issue: 3 | Pages: 931-934

10.1016/j.juro.2012.09.076 | PMID 23017526 Get It

Faculty Opinions recommendation of A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.
Shah, Vijay H.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 19, 2012 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.10361.467849 Get It